Correlation Between Invivyd and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Invivyd and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invivyd and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invivyd and Black Diamond Therapeutics, you can compare the effects of market volatilities on Invivyd and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invivyd with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invivyd and Black Diamond.
Diversification Opportunities for Invivyd and Black Diamond
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Invivyd and Black is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Invivyd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invivyd are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Invivyd i.e., Invivyd and Black Diamond go up and down completely randomly.
Pair Corralation between Invivyd and Black Diamond
Given the investment horizon of 90 days Invivyd is expected to generate 5.29 times more return on investment than Black Diamond. However, Invivyd is 5.29 times more volatile than Black Diamond Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 46.00 in Invivyd on December 29, 2024 and sell it today you would earn a total of 15.00 from holding Invivyd or generate 32.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Invivyd vs. Black Diamond Therapeutics
Performance |
Timeline |
Invivyd |
Black Diamond Therap |
Invivyd and Black Diamond Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Invivyd and Black Diamond
The main advantage of trading using opposite Invivyd and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invivyd position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.Invivyd vs. Recursion Pharmaceuticals | Invivyd vs. Atea Pharmaceuticals | Invivyd vs. Unity Biotechnology | Invivyd vs. Regenxbio |
Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |